These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9873532)

  • 1. Exploring structure-activity relationships around the phosphomannose isomerase inhibitor AF14049 via combinatorial synthesis.
    Bhandari A; Jones DG; Schullek JR; Vo K; Schunk CA; Tamanaha LL; Chen D; Yuan Z; Needels MC; Gallop MA
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2303-8. PubMed ID: 9873532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Saccharomyces cerevisiae phosphomannose isomerase by the NO-donor S-nitroso-acetyl-penicillamine.
    Salvati L; Mattu M; Tiberi F; Polticelli F; Ascenzi P
    J Enzyme Inhib; 2001; 16(3):287-92. PubMed ID: 11697049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of non-hydrolyzable D-mannose 6-phosphate surrogates reveal 6-deoxy-6-dicarboxymethyl-D-mannose as a new strong inhibitor of phosphomannose isomerases.
    Foret J; de Courcy B; Gresh N; Piquemal JP; Salmon L
    Bioorg Med Chem; 2009 Oct; 17(20):7100-7. PubMed ID: 19783448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of fungal and mammalian phosphomannose isomerases.
    Proudfoot AE; Payton MA; Wells TN
    J Protein Chem; 1994 Oct; 13(7):619-27. PubMed ID: 7702743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarizable water networks in ligand-metalloprotein recognition. Impact on the relative complexation energies of Zn-dependent phosphomannose isomerase with D-mannose 6-phosphate surrogates.
    Gresh N; de Courcy B; Piquemal JP; Foret J; Courtiol-Legourd S; Salmon L
    J Phys Chem B; 2011 Jun; 115(25):8304-16. PubMed ID: 21650197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphomannose isomerase by mercury ions.
    Wells TN; Payton MA; Proudfoot AE
    Biochemistry; 1994 Jun; 33(24):7641-6. PubMed ID: 8011630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 5-phospho-D-arabinonohydroxamate and 5-phospho-D-arabinonate inhibitors to zinc phosphomannose isomerase from Candida albicans studied by polarizable molecular mechanics and quantum mechanics.
    Roux C; Gresh N; Perera LE; Piquemal JP; Salmon L
    J Comput Chem; 2007 Apr; 28(5):938-57. PubMed ID: 17253648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cys-150 in the active site of phosphomannose isomerase from Candida albicans.
    Coulin F; Magnenat E; Proudfoot AE; Payton MA; Scully P; Wells TN
    Biochemistry; 1993 Dec; 32(51):14139-44. PubMed ID: 8260497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine 304 is an active site residue in phosphomannose isomerase from Candida albicans.
    Wells TN; Scully P; Magnenat E
    Biochemistry; 1994 May; 33(19):5777-82. PubMed ID: 8180205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution.
    Cleasby A; Wonacott A; Skarzynski T; Hubbard RE; Davies GJ; Proudfoot AE; Bernard AR; Payton MA; Wells TN
    Nat Struct Biol; 1996 May; 3(5):470-9. PubMed ID: 8612079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of phosphomannose isomerase from Candida albicans complexed with 5-phospho-d-arabinonhydrazide.
    Ahmad L; Plancqueel S; Dubosclard V; Lazar N; Ghattas W; Li de la Sierra-Gallay I; van Tilbeurgh H; Salmon L
    FEBS Lett; 2018 May; 592(10):1667-1680. PubMed ID: 29687459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain organisation in phosphomannose isomerases (types I and II).
    Jensen SO; Reeves PR
    Biochim Biophys Acta; 1998 Jan; 1382(1):5-7. PubMed ID: 9507048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of type I and type II phosphomannose isomerases by the reaction intermediate analogue 5-phospho-D-arabinonohydroxamic acid supports a catalytic role for the metal cofactor.
    Roux C; Lee JH; Jeffery CJ; Salmon L
    Biochemistry; 2004 Mar; 43(10):2926-34. PubMed ID: 15005628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and heterologous expression of the Candida albicans gene PMI 1 encoding phosphomannose isomerase.
    Smith DJ; Proudfoot AE; Detiani M; Wells TN; Payton MA
    Yeast; 1995 Apr; 11(4):301-10. PubMed ID: 7785330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase.
    Tolley S; Davies G; Hubbard RE; Smith DJ; Proudfoot AE; Payton MA; Cleasby A; Wonacott A; Wells TN
    J Mol Biol; 1994 Apr; 237(3):349-50. PubMed ID: 8145246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of malonate-based inhibitors of phosphosugar-metabolizing enzymes: class II fructose-1,6-bis-phosphate aldolases, type I phosphomannose isomerase, and phosphoglucose isomerase.
    Desvergnes S; Courtiol-Legourd S; Daher R; Dabrowski M; Salmon L; Therisod M
    Bioorg Med Chem; 2012 Feb; 20(4):1511-20. PubMed ID: 22269276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenomethionine labelling of phosphomannose isomerase changes its kinetic properties.
    Bernard AR; Wells TN; Cleasby A; Borlat F; Payton MA; Proudfoot AE
    Eur J Biochem; 1995 May; 230(1):111-8. PubMed ID: 7601089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction mechanism of type I phosphomannose isomerases: new information from inhibition and polarizable molecular mechanics studies.
    Roux C; Bhatt F; Foret J; de Courcy B; Gresh N; Piquemal JP; Jeffery CJ; Salmon L
    Proteins; 2011 Jan; 79(1):203-20. PubMed ID: 21058398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.